Pharmacokinetic and pharmacodynamic profile of the sodium ‐glucose co‐transporter‐2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial

Diabetic Medicine, EarlyView.

Source: Diabetic Medicine - May 7, 2018 Category: Endocrinology Authors: L. M. B. Laffel , W. V. Tamborlane , A. Yver , G. Simons , J. Wu , V. Nock , D. Hobson , K. S. Hughan , S. Kaspers , J. Marquard Source Type: research